CeMines Estonian Subsidiary Co-Founds Cancer Diagnostics and Therapeutics Firm | GenomeWeb

NEW YORK, Jan. 11 (GenomeWeb News) - CeMines Estonia OU, a subsidiary of CeMines International, has co-founded VTAK, a privately held company focused on researching and commercializing cancer diagnostics and therapeutics, CeMines said yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.